halofenate has been researched along with Body Weight in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mandel, LR | 1 |
Bassett, DR; Block, WD; Buckingham, RB; DiGaetano, R; Liou, LL; Mikkelsen, WM; Shakibai, A; Sidiq, M | 1 |
Anthony, LE; Jones, AL | 1 |
Hamilton, RD; Hearn, T; Kanner, IF; Rees, ED; Wasson, S | 1 |
Edwards, KD; Schapel, GJ | 1 |
2 trial(s) available for halofenate and Body Weight
Article | Year |
---|---|
Effects of halofenate and probenecid on serum lipids and uric acid in hyperlipidemic, hyperuricemic adults.
Topics: Adult; Aged; Body Weight; Cholesterol; Clinical Trials as Topic; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Obesity; Probenecid; Triglycerides; Uric Acid | 1977 |
Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
Topics: Adult; Blood Chemical Analysis; Body Weight; Cholesterol; Clinical Trials as Topic; Clofibrate; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Male; Middle Aged; Triglycerides | 1976 |
3 other study(ies) available for halofenate and Body Weight
Article | Year |
---|---|
Studies on the mechanism of action of halofenate.
Topics: Adipose Tissue; Animals; Apolipoproteins; Blood Glucose; Body Weight; Cholesterol; Fasting; Glycolates; Halofenate; Hydroxymethylglutaryl CoA Reductases; Lipoproteins; Liver; Male; Organ Specificity; Rats; Saccharomyces cerevisiae; Species Specificity; Triglycerides; Uric Acid | 1977 |
Influence of 2-acetoamidoethyl (p-chloro-phenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on hepatic drug metabolism in retired breeder rats.
Topics: Animals; Biotransformation; Body Weight; Cytochromes; Ethylmorphine-N-Demethylase; Glycolates; Halofenate; Lipid Metabolism; Lipids; Liver; Male; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Organ Size; Proteins; Rats | 1977 |
Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
Topics: Animals; Body Weight; Butyrates; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; Glycolates; Halofenate; Hyperlipidemias; Lipids; Liver; Nephrotic Syndrome; Organ Size; Oxandrolone; Puromycin Aminonucleoside; Rats; Statistics as Topic | 1975 |